Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.

Kleczko EK, Kwak JW, Schenk EL, Nemenoff RA.

Front Immunol. 2019 May 10;10:954. doi: 10.3389/fimmu.2019.00954. eCollection 2019. Review.

2.

Tumor-intrinsic response to IFN╬│ shapes the tumor microenvironment and anti-PD-1 response in NSCLC.

Bullock BL, Kimball AK, Poczobutt JM, Neuwelt AJ, Li HY, Johnson AM, Kwak JW, Kleczko EK, Kaspar RE, Wagner EK, Hopp K, Schenk EL, Weiser-Evans MC, Clambey ET, Nemenoff RA.

Life Sci Alliance. 2019 May 27;2(3). pii: e201900328. doi: 10.26508/lsa.201900328. Print 2019 Jun.

3.

Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.

Schenk EL, Koh BD, Flatten KS, Peterson KL, Parry D, Hess AD, Smith BD, Karp JE, Karnitz LM, Kaufmann SH.

Clin Cancer Res. 2012 Oct 1;18(19):5364-73. doi: 10.1158/1078-0432.CCR-12-0961. Epub 2012 Aug 6.

4.

Retraction: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.

Cabrera R, Schenk EL, Nava-Parada P, Bell MP, Van Keulen VP, Marler RJ, Felts SJ, Pease LR.

J Immunol. 2010 Jun 1;184(11):6556. doi: 10.4049/jimmunol.1090035. No abstract available.

5.
6.

Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situ.

Heckman KL, Schenk EL, Radhakrishnan S, Pavelko KD, Hansen MJ, Pease LR.

Eur J Immunol. 2007 Jul;37(7):1827-35.

7.

HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.

Hildebrand WH, Turnquist HR, Prilliman KR, Hickman HD, Schenk EL, McIlhaney MM, Solheim JC.

Hum Immunol. 2002 Apr;63(4):248-55. Review.

PMID:
12039406
8.

The interface between tapasin and MHC class I: identification of amino acid residues in both proteins that influence their interaction.

Turnquist HR, Vargas SE, Schenk EL, McIlhaney MM, Reber AJ, Solheim JC.

Immunol Res. 2002;25(3):261-9. Review.

PMID:
12018464
9.

Disparate binding of chaperone proteins by HLA-A subtypes.

Turnquist HR, Schenk EL, McIlhaney MM, Hickman HD, Hildebrand WH, Solheim JC.

Immunogenetics. 2002 Feb;53(10-11):830-4. Epub 2002 Jan 22.

PMID:
11862383

Supplemental Content

Loading ...
Support Center